Scientists develop new drug that combats two ‘priority pathogens’


Posted in: Device / Technology News | Medical Research News | Pharmaceutical News

Tags: Acinetobacter, Acinetobacter Baumannii, Antibiotic, Antibiotic Resistance, Antimicrobial Resistance, Bacteria, Campylobacter, Chlamydia, Drugs, Enterococcus, Fluoroquinolone, Genomic, Helicobacter pylori, Hospital, Infectious Diseases, Nutrition, Pathogen, Pathophysiology, Pharmacology, Physiology, Proliferation, Public Health, Respiratory, Staphylococcus aureus, Toxicology